What is NeuroOne Medical Technologies Quick Ratio?
NeuroOne Medical TechnologiesNMTC +2.77%43 Quick Ratio is 3.28 as of Mar. 2026, which is 110% above its 10-year median of 1.56. GuruFocus rates NMTC with a GF Score™ of 43/100 and a GF Value™ of $6.58 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 854 Medical Devices & Instruments companies, NeuroOne Medical Technologies ranks better than 70.61% on this metric.
NeuroOne Medical Technologies has a quick ratio of 3.28. It generally indicates good short-term financial strength.
The historical rank and industry rank for NeuroOne Medical Technologies's Quick Ratio or its related term are showing as below:
NMTC'
s Quick Ratio Range Over the Past 10 Years
Min: 0.01 Med: 1.56 Max: 16.32
Current: 3.28
During the past 13 years, NeuroOne Medical Technologies's highest Quick Ratio was 16.32. The lowest was 0.01. And the median was 1.56.
NMTC's Quick Ratio is ranked better than 70.61% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs NMTC: 3.28
NeuroOne Medical Technologies (NAS:NMTC) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
NeuroOne Medical Technologies Quick Ratio Related Terms
NeuroOne Medical Technologies Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, NeuroOne Medical Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuroOne Medical Technologies Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Quick Ratio distribution charts can be found below:
* The bar in red indicates where NeuroOne Medical Technologies's Quick Ratio falls into.
NeuroOne Medical Technologies Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuroOne Medical Technologies (NMTC) has a Quick Ratio of 3.28 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on NeuroOne Medical Technologies and its competitors. This is 110% above median its historical median of 1.56. Over the past decade, NeuroOne Medical Technologies' Quick Ratio has ranged from 0.01 to 16.32. According to the industry distribution chart, NeuroOne Medical Technologies ranks #251 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 29.4%.
Is NeuroOne Medical Technologies' Quick Ratio too high?
NeuroOne Medical Technologies' current Quick Ratio of 3.28 is 110% above median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 16.32. The Medical Devices & Instruments industry median Quick Ratio is 1.87. NeuroOne Medical Technologies' value of 3.28 is 75.9% above this industry median. Based on the distribution chart, NeuroOne Medical Technologies ranks #251 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, NeuroOne Medical Technologies has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NeuroOne Medical Technologies' Quick Ratio compare to CTSO and CODX?
According to the Medical Devices & Instruments industry distribution chart, NeuroOne Medical Technologies ranks #251 out of 854 companies for Quick Ratio. This puts NeuroOne Medical Technologies in the upper half of its industry. The industry median Quick Ratio is 1.87. NeuroOne Medical Technologies' value of 3.28 is 75.9% above this benchmark. Historically, NeuroOne Medical Technologies' own Quick Ratio has ranged from 0.01 to 16.32 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 1.87, NeuroOne Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeuroOne Medical Technologies's current Quick Ratio of 3.28 is 75.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on NeuroOne Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeuroOne Medical Technologies's current Quick Ratio is 3.28, which is 110% above median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroOne Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, NeuroOne Medical Technologies (NMTC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.58, compared to a current price of $3.30 — trading 49.8% below its estimated fair value. The current Quick Ratio is 3.28, which is 110% above median its 10-year median of 1.56 and 75.9% above the Medical Devices & Instruments industry median of 1.87. NeuroOne Medical Technologies' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For NeuroOne Medical Technologies (NMTC), the current Quick Ratio is 3.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeuroOne Medical Technologies (NMTC) Overvalued in 2026?
Based on GuruFocus' analysis, NeuroOne Medical Technologies stock appears to be undervalued.
The current stock price of $3.30 is trading 49.8% below its estimated GF Value™ of $6.58.
GuruFocus considers NeuroOne Medical Technologies to be Possible Value Trap.
Key valuation signals for NMTC:
Quick Ratio: 3.28 (110% above median its 10-year median of 1.56)
GF Value™: $6.58 vs. price of $3.30 (49.8% below fair value)
Industry Position: 75.9% above the Medical Devices & Instruments median (#251 of 854)
No single metric tells the full story. See the NMTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeuroOne Medical Technologies Business Description
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
43GF Score
Get the complete analysis for NMTC
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NMTC has been successfully added to your 
